Literature DB >> 30686540

Standardised virtual fracture clinic management of Achilles tendon ruptures is safe and reproducible.

Alastair Robertson1, Charles Godavitarne2, Simon Bellringer3, Enis Guryel2, Felicity Auld2, Lucy Cassidy4, James Gibbs2.   

Abstract

BACKGROUND: Traditional fracture clinics are some of the busiest clinics in a hospital, often with significant patient waiting times and delays. The use of virtual fracture clinic (VFC) for the management of certain injuries to reduce the workload on the traditional fracture clinic, in addition to reducing costs is growing in popularity. The tendoachilles is the most frequently ruptured tendon in the body but despite this, management remains a keenly debated topic.
METHODS: All adult patients referred to the VFC with an actual or suspected Achilles tendon rupture were identified between January 2015 to October 2017.
RESULTS: This study found that patient with and acute achilles tendon ruptures managed according to a standardised VFC protocol had a re-rupture rate of 3.82%.
CONCLUSIONS: One of the advantages of a VFC model that is standardised, initiated in the ED, is that it has no variation in outcome seen in our patient group. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  TA; Tendoachilles; Virtual Fracture Clinic

Mesh:

Year:  2018        PMID: 30686540     DOI: 10.1016/j.fas.2018.10.010

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  2 in total

Review 1.  How useful are virtual fracture clinics?: a systematic review.

Authors:  Shehzaad A Khan; Ajay Asokan; Charles Handford; Peter Logan; Thomas Moores
Journal:  Bone Jt Open       Date:  2020-11-01

2.  Are Virtual Fracture Clinics During the COVID-19 Pandemic a Potential Alternative for Delivering Fracture Care? A Systematic Review.

Authors:  Evelyn P Murphy; Christopher Fenelon; Robert P Murphy; Michael D O'Sullivan; Eoghan Pomeroy; Eoin Sheehan; David P Moore
Journal:  Clin Orthop Relat Res       Date:  2020-11       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.